Skip to main content
MarketsSingle-sourceLow
2.0

Tonix Pharmaceuticals reports executive or director departure via 8-K filing

Tonix Pharmaceuticals Holding Corp. filed an 8-K disclosing a change in corporate governance or executive leadership under Item 5.02. The specific identity of the departing individual and the impact on company strategy remain unconfirmed pending further disclosure.

SEC EDGAR 8-K Filings3 days agoUSCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Confidence0.9
Significance0.1
Source credibility0.1
Source

Related signals

8 found